Wei-Ying Lin
Mackay Memorial Hospital
11 Papers
22 Citations
Wei-Ying Lin is an academic researcher from Mackay Memorial Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia
TL;DR: To evaluate the treatment results of central nervous system preventive therapy with triple intrathecal therapy (TIT) alone in children with acute lymphoblastic leukemia (ALL).
22
Arsenic trioxide-induced cardiotoxicity triggers ferroptosis in cardiomyoblast cells
Linya Wang,Shu-Guang Liu,Chao Gao,Hui Chen,Jing Li,Jiran Lu,Yuan Yuan,Xueling Zheng,H Y He,Xixi Zhang,Yuanyuan Zhang,Ying Wu,Wei-Ying Lin,Huyong Zheng +13 more
TL;DR: The cardioprotective effect of Fer-1 against ATO-induced cell injury implies that ATO may trigger ferroptosis to induce cardiotoxicity, and lays the foundation for exploring the potential value of ferroPTosis inhibitors against ATo-induced cardiot toxicity in the future.
14
Venetoclax as a cytoreduction therapy for acute promyelocytic leukaemia: A single-centre experience.
Peijing Qi,Linya Wang,Hongqiao Li,Ying Wu,Jia Fan,Peng-Li Huang,Bei Hou,Jie Yang,Huiqing Liu,Jiaole Yu,Wei-Ying Lin,Yuanyuan Zhang,Ruidong Zhang,Yu Lu,Yan Liu,Huyong Zheng +15 more
TL;DR: This single-centre study evaluates venetoclax as a cytoreduction therapy for paediatric acute promyelocytic leukaemia, demonstrating its efficacy and safety, with improved outcomes and reduced reliance on platelet and plasma infusions compared to traditional cytoreduction therapy.
3
Enteral nutrition for children with acute leukemia-related pancreatitis
TL;DR: In this paper , the clinical efficacy of EN for children with leukemia-related pancreatitis was evaluated and early EN was found to be a protective factor from secondary infection and significant weight loss.
Prognostic significance of NOTCH1/FBXW7 mutations in pediatric T cell acute lymphoblastic leukemia: a study of minimal residual disease risk-directed CCLG-ALL 2008 treatment protocol
TL;DR: In this article , the NotCH1/FBXW7 mutations were analyzed by Sanger sequencing, and MRD was evaluated by flow cytometry, and the results indicated that the NOTCH1 mutation predicted a favorable outcome in pediatric T-ALL and may be considered a risk stratification factor.